Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Neuland Laboratories Limited (NSE: NEULANDLAB), ISIN INE794A01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NEULANDLAB last traded at ₹22493.30 (-0.16%), with a 52-week range of ₹11500.00 to ₹24235.05 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 32.62%, FIIs 21.08%, DIIs 16.51%, mutual funds 12.66%.
EquiSense Score (ECS): 71/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.